 Alexander Horswill
Concepts (624)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 102 | 2024 | 385 | 24.370 |
Why?
| | Staphylococcal Infections | 87 | 2024 | 337 | 21.960 |
Why?
| | Bacterial Proteins | 78 | 2023 | 739 | 11.710 |
Why?
| | Biofilms | 51 | 2023 | 222 | 10.370 |
Why?
| | Quorum Sensing | 34 | 2023 | 72 | 8.860 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 35 | 2023 | 193 | 7.980 |
Why?
| | Staphylococcus epidermidis | 23 | 2023 | 71 | 5.660 |
Why?
| | Gene Expression Regulation, Bacterial | 36 | 2022 | 284 | 4.850 |
Why?
| | Staphylococcus | 11 | 2022 | 69 | 3.730 |
Why?
| | Virulence Factors | 23 | 2022 | 139 | 3.620 |
Why?
| | Virulence | 27 | 2023 | 231 | 3.370 |
Why?
| | Trans-Activators | 18 | 2023 | 370 | 3.330 |
Why?
| | Peptides, Cyclic | 19 | 2019 | 262 | 3.180 |
Why?
| | Anti-Bacterial Agents | 31 | 2023 | 1485 | 2.960 |
Why?
| | Skin | 15 | 2022 | 662 | 2.720 |
Why?
| | Peptides | 16 | 2024 | 864 | 2.370 |
Why?
| | Staphylococcal Skin Infections | 8 | 2021 | 29 | 2.370 |
Why?
| | Host-Pathogen Interactions | 14 | 2024 | 296 | 1.990 |
Why?
| | Protein Kinases | 8 | 2022 | 306 | 1.820 |
Why?
| | Bacterial Adhesion | 10 | 2022 | 78 | 1.810 |
Why?
| | Neutrophils | 19 | 2023 | 1172 | 1.720 |
Why?
| | Hemolysin Proteins | 9 | 2018 | 31 | 1.630 |
Why?
| | Animals | 79 | 2023 | 32104 | 1.400 |
Why?
| | Mice | 53 | 2023 | 15052 | 1.390 |
Why?
| | Phagocytosis | 10 | 2023 | 355 | 1.320 |
Why?
| | Bacterial Toxins | 12 | 2020 | 103 | 1.320 |
Why?
| | Lipoproteins | 4 | 2024 | 162 | 1.310 |
Why?
| | Coinfection | 4 | 2023 | 120 | 1.300 |
Why?
| | Immune Evasion | 7 | 2021 | 47 | 1.230 |
Why?
| | Peptide Hydrolases | 10 | 2023 | 109 | 1.160 |
Why?
| | Fibrinogen | 6 | 2023 | 160 | 1.090 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 81 | 1.080 |
Why?
| | Microbial Interactions | 2 | 2019 | 14 | 1.070 |
Why?
| | Polysaccharide-Lyases | 2 | 2016 | 13 | 1.020 |
Why?
| | Streptococcus pyogenes | 2 | 2023 | 33 | 1.000 |
Why?
| | Repressor Proteins | 4 | 2015 | 369 | 0.980 |
Why?
| | Humans | 94 | 2024 | 115741 | 0.920 |
Why?
| | Dermatitis, Atopic | 3 | 2022 | 310 | 0.920 |
Why?
| | Membrane Proteins | 7 | 2022 | 1024 | 0.910 |
Why?
| | Extracellular Space | 4 | 2014 | 122 | 0.890 |
Why?
| | Endodeoxyribonucleases | 1 | 2023 | 59 | 0.840 |
Why?
| | DNA, Bacterial | 6 | 2020 | 309 | 0.840 |
Why?
| | Bacteremia | 4 | 2020 | 159 | 0.810 |
Why?
| | Adhesins, Bacterial | 8 | 2023 | 35 | 0.810 |
Why?
| | Propionates | 7 | 2020 | 33 | 0.810 |
Why?
| | Microbial Sensitivity Tests | 13 | 2023 | 299 | 0.800 |
Why?
| | Cathepsin G | 1 | 2021 | 6 | 0.770 |
Why?
| | Metalloproteases | 2 | 2020 | 37 | 0.770 |
Why?
| | Microbiota | 6 | 2022 | 653 | 0.770 |
Why?
| | Micrococcal Nuclease | 6 | 2014 | 19 | 0.760 |
Why?
| | Agglutination Tests | 1 | 2021 | 2 | 0.750 |
Why?
| | Cell Membrane | 7 | 2021 | 683 | 0.750 |
Why?
| | Symbiosis | 2 | 2020 | 65 | 0.750 |
Why?
| | Microbial Viability | 3 | 2018 | 79 | 0.720 |
Why?
| | Metalloendopeptidases | 5 | 2017 | 55 | 0.720 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 477 | 0.720 |
Why?
| | Mutation | 25 | 2021 | 3364 | 0.710 |
Why?
| | Mass Spectrometry | 8 | 2019 | 645 | 0.690 |
Why?
| | Plant Extracts | 4 | 2020 | 153 | 0.660 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 62 | 0.660 |
Why?
| | Rabbits | 10 | 2019 | 752 | 0.650 |
Why?
| | Immunity, Innate | 8 | 2021 | 731 | 0.650 |
Why?
| | Membrane Transport Proteins | 1 | 2020 | 137 | 0.650 |
Why?
| | Mice, Inbred C57BL | 18 | 2021 | 4773 | 0.640 |
Why?
| | Dehydration | 1 | 2018 | 38 | 0.620 |
Why?
| | Yersinia pestis | 3 | 2013 | 34 | 0.610 |
Why?
| | Antibiosis | 1 | 2017 | 7 | 0.610 |
Why?
| | Disease Transmission, Infectious | 1 | 2018 | 57 | 0.600 |
Why?
| | Carrier Proteins | 4 | 2022 | 701 | 0.580 |
Why?
| | Salmonella typhimurium | 7 | 2004 | 161 | 0.580 |
Why?
| | Operating Rooms | 1 | 2018 | 87 | 0.580 |
Why?
| | Catheter-Related Infections | 8 | 2022 | 61 | 0.570 |
Why?
| | Pseudomonas aeruginosa | 7 | 2023 | 301 | 0.560 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.560 |
Why?
| | Cysteine Endopeptidases | 2 | 2013 | 61 | 0.540 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.520 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.520 |
Why?
| | Genes, Bacterial | 8 | 2014 | 156 | 0.510 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.510 |
Why?
| | Bacteriological Techniques | 2 | 2014 | 65 | 0.510 |
Why?
| | Models, Molecular | 11 | 2021 | 1390 | 0.500 |
Why?
| | Mice, Inbred BALB C | 7 | 2022 | 1168 | 0.500 |
Why?
| | Lactones | 2 | 2013 | 56 | 0.490 |
Why?
| | Transduction, Genetic | 2 | 2014 | 114 | 0.490 |
Why?
| | Gram-Positive Bacteria | 2 | 2017 | 46 | 0.490 |
Why?
| | Extracellular Matrix | 3 | 2020 | 439 | 0.480 |
Why?
| | Hyaluronic Acid | 1 | 2016 | 190 | 0.470 |
Why?
| | Endonucleases | 1 | 2014 | 30 | 0.460 |
Why?
| | Environment | 1 | 2016 | 337 | 0.460 |
Why?
| | Disease Models, Animal | 18 | 2023 | 3580 | 0.460 |
Why?
| | Peptide Library | 6 | 2007 | 81 | 0.460 |
Why?
| | beta-Lactams | 2 | 2016 | 27 | 0.440 |
Why?
| | Bacteriophages | 2 | 2014 | 76 | 0.440 |
Why?
| | Citrates | 4 | 2004 | 44 | 0.430 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 9 | 0.430 |
Why?
| | Salmonella enterica | 5 | 2003 | 51 | 0.430 |
Why?
| | Plasmids | 7 | 2013 | 345 | 0.430 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1316 | 0.430 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 847 | 0.420 |
Why?
| | Sigma Factor | 2 | 2011 | 33 | 0.420 |
Why?
| | Bone Remodeling | 1 | 2013 | 65 | 0.420 |
Why?
| | Bacillus thuringiensis | 1 | 2012 | 4 | 0.420 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.420 |
Why?
| | Berberine | 1 | 2012 | 6 | 0.420 |
Why?
| | Mutagenesis | 2 | 2012 | 170 | 0.410 |
Why?
| | Superantigens | 4 | 2013 | 69 | 0.410 |
Why?
| | Synovial Fluid | 4 | 2022 | 57 | 0.410 |
Why?
| | Gene Library | 2 | 2010 | 117 | 0.410 |
Why?
| | Fibronectins | 3 | 2022 | 108 | 0.400 |
Why?
| | Pneumonia, Bacterial | 2 | 2023 | 107 | 0.400 |
Why?
| | Keratinocytes | 5 | 2023 | 215 | 0.400 |
Why?
| | Osteomyelitis | 1 | 2013 | 103 | 0.390 |
Why?
| | Locomotion | 1 | 2012 | 81 | 0.390 |
Why?
| | Coagulase | 3 | 2021 | 6 | 0.390 |
Why?
| | Community-Acquired Infections | 2 | 2010 | 141 | 0.390 |
Why?
| | Epithelial Cells | 3 | 2016 | 961 | 0.380 |
Why?
| | Wound Infection | 2 | 2023 | 30 | 0.380 |
Why?
| | Proteins | 3 | 2006 | 920 | 0.380 |
Why?
| | Cytotoxins | 3 | 2024 | 17 | 0.380 |
Why?
| | Genes, Reporter | 3 | 2019 | 257 | 0.380 |
Why?
| | Extracellular Traps | 2 | 2021 | 40 | 0.380 |
Why?
| | Serine Endopeptidases | 3 | 2011 | 102 | 0.380 |
Why?
| | Coenzyme A Ligases | 3 | 2003 | 11 | 0.370 |
Why?
| | Hydrogen-Ion Concentration | 4 | 2022 | 515 | 0.360 |
Why?
| | Plasma | 1 | 2012 | 213 | 0.350 |
Why?
| | Luminescent Proteins | 3 | 2011 | 169 | 0.340 |
Why?
| | Internal Fixators | 1 | 2010 | 39 | 0.340 |
Why?
| | Peptide Biosynthesis | 1 | 2009 | 13 | 0.340 |
Why?
| | Models, Biological | 8 | 2021 | 1646 | 0.330 |
Why?
| | Amino Acid Sequence | 11 | 2016 | 2000 | 0.330 |
Why?
| | Anacardiaceae | 2 | 2020 | 4 | 0.320 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2790 | 0.320 |
Why?
| | Anti-Infective Agents | 4 | 2023 | 225 | 0.320 |
Why?
| | Operon | 6 | 2018 | 59 | 0.320 |
Why?
| | Polysaccharides | 3 | 2021 | 80 | 0.320 |
Why?
| | Drug Discovery | 3 | 2019 | 124 | 0.310 |
Why?
| | Cells, Cultured | 9 | 2021 | 3914 | 0.310 |
Why?
| | Recombinant Proteins | 7 | 2015 | 1243 | 0.310 |
Why?
| | Sepsis | 3 | 2023 | 515 | 0.300 |
Why?
| | Signal Transduction | 9 | 2021 | 4541 | 0.300 |
Why?
| | DnaB Helicases | 1 | 2007 | 3 | 0.300 |
Why?
| | Inteins | 1 | 2007 | 3 | 0.300 |
Why?
| | Synechocystis | 1 | 2007 | 4 | 0.300 |
Why?
| | Cysteine Proteases | 2 | 2020 | 3 | 0.290 |
Why?
| | Protein Binding | 8 | 2017 | 1917 | 0.290 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1122 | 0.290 |
Why?
| | Cyclohexanones | 2 | 2017 | 8 | 0.280 |
Why?
| | Biological Assay | 3 | 2015 | 114 | 0.270 |
Why?
| | Protein Engineering | 2 | 2004 | 104 | 0.260 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2014 | 352 | 0.260 |
Why?
| | Base Sequence | 4 | 2023 | 2114 | 0.260 |
Why?
| | Inflammation | 8 | 2023 | 2500 | 0.250 |
Why?
| | Escherichia coli | 3 | 2009 | 730 | 0.250 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 2023 | 76 | 0.240 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1265 | 0.240 |
Why?
| | Female | 24 | 2022 | 60018 | 0.240 |
Why?
| | Molecular Biology | 1 | 2005 | 56 | 0.240 |
Why?
| | Aconitate Hydratase | 2 | 2002 | 17 | 0.240 |
Why?
| | Coculture Techniques | 2 | 2016 | 202 | 0.240 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1044 | 0.240 |
Why?
| | Vagina | 2 | 2019 | 148 | 0.240 |
Why?
| | Endocarditis | 2 | 2016 | 32 | 0.240 |
Why?
| | Structure-Activity Relationship | 3 | 2023 | 511 | 0.240 |
Why?
| | Isocitrates | 2 | 2001 | 2 | 0.240 |
Why?
| | Oxo-Acid-Lyases | 2 | 2001 | 3 | 0.240 |
Why?
| | Biology | 1 | 2005 | 78 | 0.230 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 156 | 0.230 |
Why?
| | Succinates | 1 | 2023 | 18 | 0.230 |
Why?
| | Receptor, PAR-1 | 1 | 2023 | 21 | 0.230 |
Why?
| | Dermatitis | 1 | 2023 | 17 | 0.220 |
Why?
| | Swine | 4 | 2017 | 706 | 0.220 |
Why?
| | Pruritus | 1 | 2023 | 60 | 0.220 |
Why?
| | alpha-Defensins | 2 | 2021 | 11 | 0.220 |
Why?
| | Microscopy, Confocal | 3 | 2014 | 299 | 0.220 |
Why?
| | Enzymes | 1 | 2004 | 61 | 0.220 |
Why?
| | Streptococcal Infections | 2 | 2023 | 132 | 0.210 |
Why?
| | RNA, Bacterial | 4 | 2013 | 173 | 0.210 |
Why?
| | Respiratory System | 2 | 2016 | 141 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2016 | 402 | 0.210 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 168 | 0.210 |
Why?
| | Male | 21 | 2022 | 56050 | 0.210 |
Why?
| | Lipase | 2 | 2021 | 66 | 0.210 |
Why?
| | Exotoxins | 2 | 2013 | 14 | 0.210 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2023 | 60 | 0.210 |
Why?
| | Staphylococcus hominis | 1 | 2022 | 1 | 0.210 |
Why?
| | DNA Transposable Elements | 4 | 2010 | 100 | 0.210 |
Why?
| | Cephalexin | 1 | 2022 | 8 | 0.210 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2023 | 161 | 0.200 |
Why?
| | Genotype | 4 | 2019 | 1787 | 0.200 |
Why?
| | Polysaccharides, Bacterial | 3 | 2017 | 65 | 0.200 |
Why?
| | Bacterial Load | 4 | 2015 | 60 | 0.200 |
Why?
| | Cell Communication | 2 | 2018 | 282 | 0.200 |
Why?
| | Epidermis | 2 | 2020 | 149 | 0.200 |
Why?
| | Basophils | 1 | 2021 | 64 | 0.190 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 50 | 0.190 |
Why?
| | Cell Death | 2 | 2021 | 326 | 0.190 |
Why?
| | Lectins | 1 | 2021 | 46 | 0.190 |
Why?
| | Macrophages | 4 | 2023 | 1284 | 0.190 |
Why?
| | Propionibacteriaceae | 1 | 2020 | 1 | 0.190 |
Why?
| | Interleukin-17 | 2 | 2019 | 106 | 0.190 |
Why?
| | Pyruvic Acid | 1 | 2001 | 41 | 0.190 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2001 | 64 | 0.190 |
Why?
| | Hair Follicle | 1 | 2021 | 44 | 0.190 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 1001 | 0.190 |
Why?
| | Orthopedic Equipment | 1 | 2020 | 5 | 0.180 |
Why?
| | Interleukin-4 | 1 | 2021 | 209 | 0.180 |
Why?
| | Molecular Structure | 4 | 2020 | 447 | 0.180 |
Why?
| | Chemotaxis | 1 | 2021 | 132 | 0.180 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2018 | 17 | 0.180 |
Why?
| | Phage Therapy | 1 | 2020 | 6 | 0.180 |
Why?
| | Photochemotherapy | 1 | 2020 | 29 | 0.180 |
Why?
| | Fatty Acids, Volatile | 1 | 2020 | 47 | 0.180 |
Why?
| | Photosensitizing Agents | 1 | 2020 | 26 | 0.180 |
Why?
| | Dysbiosis | 1 | 2022 | 146 | 0.180 |
Why?
| | Shear Strength | 1 | 2020 | 65 | 0.180 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 66 | 0.180 |
Why?
| | Netherton Syndrome | 1 | 2020 | 2 | 0.180 |
Why?
| | Genomics | 1 | 2005 | 646 | 0.180 |
Why?
| | Triterpenes | 1 | 2020 | 17 | 0.180 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 112 | 0.180 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 804 | 0.180 |
Why?
| | Enzyme Inhibitors | 4 | 2008 | 757 | 0.180 |
Why?
| | Prosthesis-Related Infections | 2 | 2011 | 70 | 0.170 |
Why?
| | Bacteria | 3 | 2023 | 729 | 0.170 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 119 | 0.170 |
Why?
| | Pyrazines | 1 | 2020 | 70 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 83 | 0.170 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1537 | 0.170 |
Why?
| | Blotting, Western | 4 | 2016 | 1153 | 0.170 |
Why?
| | Gene Deletion | 4 | 2014 | 355 | 0.170 |
Why?
| | Streptococcus agalactiae | 2 | 2023 | 82 | 0.170 |
Why?
| | Coleoptera | 1 | 2019 | 26 | 0.170 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.170 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 40 | 0.170 |
Why?
| | Luciferases | 1 | 2019 | 140 | 0.170 |
Why?
| | Leishmania major | 1 | 2019 | 6 | 0.170 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 7 | 0.170 |
Why?
| | Fruit | 1 | 2020 | 127 | 0.170 |
Why?
| | Cathelicidins | 4 | 2023 | 39 | 0.160 |
Why?
| | Static Electricity | 1 | 2019 | 117 | 0.160 |
Why?
| | Skin Diseases | 2 | 2019 | 124 | 0.160 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 549 | 0.160 |
Why?
| | Lung | 5 | 2022 | 3673 | 0.160 |
Why?
| | Models, Genetic | 2 | 2016 | 570 | 0.160 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 12 | 0.160 |
Why?
| | Pneumonia, Staphylococcal | 2 | 2018 | 13 | 0.160 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 166 | 0.160 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 194 | 0.150 |
Why?
| | Environmental Microbiology | 1 | 2018 | 43 | 0.150 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 188 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 100 | 0.150 |
Why?
| | NADPH Oxidases | 2 | 2021 | 122 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1310 | 0.150 |
Why?
| | Bordetella bronchiseptica | 1 | 2017 | 1 | 0.150 |
Why?
| | Bordetella Infections | 1 | 2017 | 2 | 0.150 |
Why?
| | Teichoic Acids | 2 | 2022 | 12 | 0.150 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 540 | 0.150 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 221 | 0.140 |
Why?
| | Influenza, Human | 1 | 2022 | 548 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 401 | 0.140 |
Why?
| | Cell Line | 4 | 2015 | 2651 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 503 | 0.140 |
Why?
| | Culture Media | 3 | 2012 | 156 | 0.140 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 61 | 0.140 |
Why?
| | Endocarditis, Bacterial | 2 | 2013 | 36 | 0.140 |
Why?
| | Amoxicillin | 1 | 2016 | 20 | 0.130 |
Why?
| | Ligases | 1 | 2016 | 32 | 0.130 |
Why?
| | Vascular Access Devices | 1 | 2016 | 24 | 0.130 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 22 | 0.130 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 74 | 0.130 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2015 | 8 | 0.130 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 336 | 0.130 |
Why?
| | Leukocidins | 1 | 2015 | 2 | 0.130 |
Why?
| | Trachea | 1 | 2017 | 233 | 0.130 |
Why?
| | Periplasmic Binding Proteins | 1 | 2015 | 14 | 0.130 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.130 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 302 | 0.120 |
Why?
| | Carbon | 2 | 2013 | 159 | 0.120 |
Why?
| | Multigene Family | 2 | 2013 | 193 | 0.120 |
Why?
| | Toll-Like Receptor 2 | 4 | 2021 | 112 | 0.120 |
Why?
| | Enterotoxins | 2 | 2013 | 88 | 0.120 |
Why?
| | beta-Defensins | 1 | 2014 | 20 | 0.120 |
Why?
| | Penicillium | 1 | 2014 | 6 | 0.120 |
Why?
| | Anthraquinones | 1 | 2014 | 9 | 0.120 |
Why?
| | Histocytochemistry | 1 | 2014 | 78 | 0.120 |
Why?
| | Plant Leaves | 1 | 2015 | 112 | 0.120 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.120 |
Why?
| | Structural Homology, Protein | 1 | 2014 | 23 | 0.120 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2014 | 4 | 0.120 |
Why?
| | Agglutination | 1 | 2013 | 5 | 0.120 |
Why?
| | Virus Cultivation | 1 | 2014 | 25 | 0.120 |
Why?
| | Organisms, Genetically Modified | 1 | 2013 | 15 | 0.120 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.120 |
Why?
| | DNA | 3 | 2022 | 1356 | 0.110 |
Why?
| | Nociceptors | 1 | 2013 | 15 | 0.110 |
Why?
| | Cysteine | 2 | 2018 | 173 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 165 | 0.110 |
Why?
| | Acyl-Butyrolactones | 1 | 2013 | 10 | 0.110 |
Why?
| | Heparitin Sulfate | 2 | 2023 | 42 | 0.110 |
Why?
| | Cell Proliferation | 1 | 2020 | 2194 | 0.110 |
Why?
| | Transcription Factors | 5 | 2022 | 1528 | 0.110 |
Why?
| | Erythrocytes | 2 | 2015 | 589 | 0.110 |
Why?
| | Triazoles | 1 | 2014 | 132 | 0.110 |
Why?
| | Receptors, LDL | 1 | 2013 | 39 | 0.110 |
Why?
| | Apolipoproteins B | 1 | 2013 | 41 | 0.110 |
Why?
| | Nitric Oxide | 1 | 2018 | 832 | 0.110 |
Why?
| | Blotting, Northern | 1 | 2013 | 194 | 0.110 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 40 | 0.110 |
Why?
| | Endopeptidase K | 2 | 2013 | 14 | 0.110 |
Why?
| | Surface Properties | 2 | 2014 | 397 | 0.100 |
Why?
| | Receptors, Interleukin-8B | 1 | 2012 | 23 | 0.100 |
Why?
| | Plants, Medicinal | 1 | 2012 | 19 | 0.100 |
Why?
| | Protein Transport | 1 | 2014 | 400 | 0.100 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 72 | 0.100 |
Why?
| | Alleles | 3 | 2020 | 794 | 0.100 |
Why?
| | Culture Media, Conditioned | 3 | 2020 | 105 | 0.100 |
Why?
| | Mycoplasma fermentans | 1 | 2012 | 1 | 0.100 |
Why?
| | Mutagenesis, Insertional | 3 | 2009 | 60 | 0.100 |
Why?
| | Phenol | 1 | 2012 | 18 | 0.100 |
Why?
| | Enzyme Therapy | 1 | 2011 | 4 | 0.100 |
Why?
| | Tetracyclines | 1 | 2011 | 5 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2335 | 0.100 |
Why?
| | Vancomycin | 1 | 2013 | 76 | 0.100 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 18 | 0.100 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 959 | 0.100 |
Why?
| | Binding Sites | 3 | 2011 | 1177 | 0.100 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2011 | 44 | 0.100 |
Why?
| | Ribosomes | 1 | 2013 | 148 | 0.100 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 372 | 0.100 |
Why?
| | Substrate Specificity | 3 | 2007 | 357 | 0.100 |
Why?
| | Microarray Analysis | 3 | 2019 | 119 | 0.100 |
Why?
| | Conserved Sequence | 1 | 2011 | 219 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 327 | 0.090 |
Why?
| | RNA Polymerase III | 1 | 2010 | 25 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 431 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 549 | 0.090 |
Why?
| | Autolysis | 1 | 2010 | 3 | 0.090 |
Why?
| | Protease Inhibitors | 2 | 2010 | 101 | 0.090 |
Why?
| | Citrate (si)-Synthase | 2 | 2001 | 46 | 0.090 |
Why?
| | Chronic Disease | 1 | 2016 | 1598 | 0.090 |
Why?
| | Pheromones | 1 | 2010 | 24 | 0.090 |
Why?
| | Complement C3 | 1 | 2011 | 190 | 0.090 |
Why?
| | Biological Products | 1 | 2013 | 172 | 0.090 |
Why?
| | Cytokines | 4 | 2023 | 1853 | 0.090 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 69 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 699 | 0.090 |
Why?
| | Shock, Septic | 1 | 2011 | 185 | 0.080 |
Why?
| | Arthroplasty, Replacement | 1 | 2010 | 45 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 501 | 0.080 |
Why?
| | Titanium | 1 | 2010 | 74 | 0.080 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 8 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 127 | 0.080 |
Why?
| | Ligands | 1 | 2011 | 569 | 0.080 |
Why?
| | Kinetics | 3 | 2015 | 1569 | 0.080 |
Why?
| | Time Factors | 5 | 2020 | 6171 | 0.080 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2008 | 3 | 0.080 |
Why?
| | Alcoholism | 1 | 2015 | 717 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2010 | 288 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2014 | 317 | 0.080 |
Why?
| | Mice, Knockout | 4 | 2018 | 2604 | 0.080 |
Why?
| | Lipopolysaccharides | 1 | 2011 | 826 | 0.080 |
Why?
| | Polymers | 2 | 2022 | 463 | 0.070 |
Why?
| | Gene Knockout Techniques | 3 | 2013 | 99 | 0.070 |
Why?
| | Pain | 1 | 2013 | 712 | 0.070 |
Why?
| | Endopeptidase Clp | 1 | 2007 | 4 | 0.070 |
Why?
| | Genetic Complementation Test | 3 | 2014 | 61 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 391 | 0.070 |
Why?
| | Drug Synergism | 2 | 2020 | 317 | 0.070 |
Why?
| | beta-Lactamases | 1 | 2007 | 26 | 0.070 |
Why?
| | Burns | 1 | 2010 | 242 | 0.070 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6423 | 0.070 |
Why?
| | Acyl Coenzyme A | 3 | 2003 | 29 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 646 | 0.070 |
Why?
| | Stimulation, Chemical | 1 | 2006 | 57 | 0.070 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 19 | 0.070 |
Why?
| | Respiratory Tract Infections | 1 | 2010 | 323 | 0.070 |
Why?
| | Interleukin-8 | 2 | 2021 | 241 | 0.070 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2006 | 57 | 0.070 |
Why?
| | Biocompatible Materials | 1 | 2010 | 378 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2010 | 346 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 514 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 290 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 77 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1083 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2005 | 17 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 732 | 0.060 |
Why?
| | HIV Protease | 1 | 2004 | 3 | 0.060 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2004 | 7 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2005 | 57 | 0.060 |
Why?
| | Interleukin-1beta | 2 | 2019 | 370 | 0.060 |
Why?
| | Phenotype | 3 | 2021 | 2839 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2004 | 21 | 0.060 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 52 | 0.060 |
Why?
| | Middle Aged | 3 | 2020 | 27069 | 0.060 |
Why?
| | Aged | 2 | 2023 | 19294 | 0.060 |
Why?
| | Tricarboxylic Acids | 1 | 2004 | 10 | 0.060 |
Why?
| | Bacillus subtilis | 2 | 2020 | 61 | 0.060 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 14 | 0.060 |
Why?
| | Computational Biology | 2 | 2005 | 537 | 0.060 |
Why?
| | DNA Restriction Enzymes | 1 | 2004 | 54 | 0.060 |
Why?
| | Databases, Genetic | 1 | 2005 | 208 | 0.060 |
Why?
| | Indicators and Reagents | 1 | 2004 | 100 | 0.060 |
Why?
| | Oligosaccharides | 1 | 2023 | 47 | 0.060 |
Why?
| | Catalysis | 2 | 2002 | 299 | 0.060 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 95 | 0.060 |
Why?
| | Sirolimus | 1 | 2004 | 192 | 0.050 |
Why?
| | Coenzyme A | 1 | 2003 | 6 | 0.050 |
Why?
| | Acetate-CoA Ligase | 1 | 2003 | 2 | 0.050 |
Why?
| | Adult | 3 | 2020 | 30789 | 0.050 |
Why?
| | Oxidative Stress | 3 | 2014 | 1093 | 0.050 |
Why?
| | Cell Wall | 2 | 2013 | 50 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2377 | 0.050 |
Why?
| | Adenosine Monophosphate | 1 | 2003 | 49 | 0.050 |
Why?
| | Recombinases | 1 | 2022 | 6 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 6 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Protein Stability | 2 | 2013 | 162 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Leukocytes | 2 | 2015 | 281 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 18 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 795 | 0.050 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2002 | 34 | 0.050 |
Why?
| | Brain | 1 | 2013 | 2373 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Cryoprotective Agents | 1 | 2002 | 10 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 377 | 0.050 |
Why?
| | U937 Cells | 2 | 2012 | 22 | 0.050 |
Why?
| | Hydrodynamics | 1 | 2022 | 36 | 0.050 |
Why?
| | Viscosity | 1 | 2022 | 83 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 362 | 0.050 |
Why?
| | Proteolysis | 2 | 2012 | 145 | 0.050 |
Why?
| | Tyrosine | 1 | 2022 | 219 | 0.050 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 11 | 0.050 |
Why?
| | Propylene Glycol | 2 | 1998 | 9 | 0.050 |
Why?
| | Models, Chemical | 2 | 2002 | 257 | 0.050 |
Why?
| | Ecosystem | 1 | 2006 | 526 | 0.050 |
Why?
| | Lipoylation | 1 | 2021 | 16 | 0.050 |
Why?
| | Hemolysis | 2 | 2013 | 146 | 0.050 |
Why?
| | Photorhabdus | 1 | 2001 | 1 | 0.050 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2001 | 3 | 0.050 |
Why?
| | Aconitic Acid | 1 | 2001 | 1 | 0.050 |
Why?
| | Nematoda | 1 | 2001 | 5 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 67 | 0.050 |
Why?
| | Oxaloacetic Acid | 1 | 2001 | 2 | 0.050 |
Why?
| | Glutamate Synthase | 1 | 2001 | 2 | 0.050 |
Why?
| | Protein Conformation | 3 | 2016 | 822 | 0.050 |
Why?
| | Codon, Initiator | 1 | 2001 | 7 | 0.050 |
Why?
| | Cell-Free System | 1 | 2001 | 47 | 0.050 |
Why?
| | Citric Acid Cycle | 1 | 2001 | 42 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2023 | 188 | 0.050 |
Why?
| | Isobutyrates | 1 | 2020 | 1 | 0.050 |
Why?
| | Pentanoic Acids | 1 | 2020 | 2 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2002 | 483 | 0.050 |
Why?
| | Hemiterpenes | 1 | 2020 | 11 | 0.050 |
Why?
| | Sequence Deletion | 2 | 2012 | 167 | 0.050 |
Why?
| | Desmoglein 1 | 1 | 2020 | 3 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 312 | 0.050 |
Why?
| | Crystallography, X-Ray | 3 | 2011 | 408 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2002 | 431 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2020 | 112 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 489 | 0.040 |
Why?
| | Monocytes | 2 | 2013 | 507 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 66 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 953 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 1870 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 226 | 0.040 |
Why?
| | Phenols | 1 | 2020 | 82 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2019 | 74 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 1999 | 110 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 759 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 567 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2012 | 780 | 0.040 |
Why?
| | Th17 Cells | 1 | 2019 | 59 | 0.040 |
Why?
| | Interferon Type I | 1 | 2019 | 129 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 473 | 0.040 |
Why?
| | Nucleotidyltransferases | 1 | 1998 | 26 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 1998 | 64 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2020 | 462 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2019 | 433 | 0.040 |
Why?
| | Survival Analysis | 2 | 2012 | 1219 | 0.040 |
Why?
| | Iron | 1 | 2019 | 235 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 414 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2018 | 160 | 0.040 |
Why?
| | Toxins, Biological | 1 | 2017 | 11 | 0.040 |
Why?
| | Nose | 1 | 2017 | 56 | 0.040 |
Why?
| | Immunoglobulin G | 2 | 2011 | 781 | 0.040 |
Why?
| | Genes, Regulator | 1 | 1997 | 33 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2018 | 221 | 0.040 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 297 | 0.040 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 30 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 726 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 210 | 0.030 |
Why?
| | Child | 3 | 2022 | 18503 | 0.030 |
Why?
| | Ethanolamines | 1 | 1995 | 20 | 0.030 |
Why?
| | Propylene Glycols | 1 | 1995 | 26 | 0.030 |
Why?
| | DNA Polymerase I | 1 | 1995 | 26 | 0.030 |
Why?
| | Bronchi | 1 | 2017 | 250 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 577 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 867 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 52 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 15 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 97 | 0.030 |
Why?
| | Mice, Hairless | 1 | 2014 | 74 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 2014 | 54 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 133 | 0.030 |
Why?
| | Pyomyositis | 1 | 2014 | 13 | 0.030 |
Why?
| | Neisseria gonorrhoeae | 1 | 2014 | 20 | 0.030 |
Why?
| | Hypochlorous Acid | 1 | 2013 | 4 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 102 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 139 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 47 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 1919 | 0.030 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2013 | 4 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 127 | 0.030 |
Why?
| | Lymphatic Diseases | 1 | 2013 | 17 | 0.030 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 64 | 0.030 |
Why?
| | Glyoxylates | 1 | 2013 | 9 | 0.030 |
Why?
| | Fluorescence | 1 | 2014 | 154 | 0.030 |
Why?
| | Host Specificity | 1 | 2013 | 23 | 0.030 |
Why?
| | Fermentation | 1 | 2013 | 21 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1632 | 0.030 |
Why?
| | Oxidants | 1 | 2013 | 112 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 197 | 0.030 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 13 | 0.030 |
Why?
| | NADPH Oxidase 2 | 1 | 2013 | 42 | 0.030 |
Why?
| | Carbohydrates | 1 | 2013 | 57 | 0.030 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 3 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2015 | 316 | 0.030 |
Why?
| | Regulon | 1 | 2013 | 33 | 0.030 |
Why?
| | Oligonucleotides | 1 | 2014 | 137 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 90 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 124 | 0.030 |
Why?
| | Daptomycin | 1 | 2012 | 17 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 82 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2586 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2013 | 107 | 0.030 |
Why?
| | Immunoassay | 1 | 2013 | 97 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 383 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 96 | 0.030 |
Why?
| | Sus scrofa | 1 | 2012 | 45 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 76 | 0.030 |
Why?
| | Ion Transport | 1 | 2012 | 55 | 0.030 |
Why?
| | Bicarbonates | 1 | 2012 | 42 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2015 | 423 | 0.030 |
Why?
| | Body Fluids | 1 | 2012 | 58 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 130 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2014 | 793 | 0.030 |
Why?
| | Crystallization | 2 | 2003 | 138 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 287 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 304 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 83 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2012 | 94 | 0.020 |
Why?
| | Glycerophosphates | 1 | 2011 | 2 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2011 | 24 | 0.020 |
Why?
| | Hot Temperature | 1 | 2013 | 303 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 211 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 348 | 0.020 |
Why?
| | Complement C3-C5 Convertases | 1 | 2011 | 19 | 0.020 |
Why?
| | Immunoglobulin Fragments | 1 | 2011 | 15 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2011 | 30 | 0.020 |
Why?
| | Rodent Diseases | 1 | 2011 | 25 | 0.020 |
Why?
| | Complement C3b | 1 | 2011 | 30 | 0.020 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.020 |
Why?
| | Complement C3a | 1 | 2011 | 33 | 0.020 |
Why?
| | Bacitracin | 1 | 2010 | 6 | 0.020 |
Why?
| | Neomycin | 1 | 2010 | 6 | 0.020 |
Why?
| | Polymyxin B | 1 | 2010 | 21 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 139 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 23 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 92 | 0.020 |
Why?
| | Bacteriolysis | 1 | 2010 | 9 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 281 | 0.020 |
Why?
| | Gentamicins | 1 | 2010 | 42 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2011 | 198 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 930 | 0.020 |
Why?
| | Meconium | 1 | 2010 | 7 | 0.020 |
Why?
| | Action Potentials | 1 | 2013 | 410 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 102 | 0.020 |
Why?
| | Ileus | 1 | 2010 | 10 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2010 | 21 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 633 | 0.020 |
Why?
| | Fatty Acids | 1 | 2013 | 386 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 399 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 602 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2012 | 222 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 820 | 0.020 |
Why?
| | Mucus | 1 | 2010 | 55 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 399 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 64 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2010 | 58 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 309 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 765 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 34 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2262 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2010 | 165 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 288 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 837 | 0.020 |
Why?
| | Complement Activation | 1 | 2011 | 343 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 5553 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 736 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 962 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 666 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1230 | 0.020 |
Why?
| | Caulobacter crescentus | 1 | 2007 | 1 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2012 | 773 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 1970 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2824 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2574 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2353 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1756 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2164 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 200 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3122 | 0.010 |
Why?
| | Acetylation | 1 | 2003 | 212 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 17922 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 616 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 523 | 0.010 |
Why?
| | Reproduction | 1 | 2001 | 180 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1998 | 3 | 0.010 |
Why?
| | Ethanolamine | 1 | 1995 | 5 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 35 | 0.010 |
Why?
| | Rats | 1 | 1995 | 5033 | 0.000 |
Why?
|
|
Horswill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|